Skip to main content
. 2022 Sep 6;77(Suppl 1):i61–i69. doi: 10.1093/jac/dkac218

Figure 3.

Figure 3.

Percentage susceptibility rates based on CLSI breakpoints for antibiotics against S. pneumoniae isolates (n = 279) collected as part of the SOAR study in Russia in 2014–16.